Evidence map›Paper›PMID 28466107›Full record

ArticleCancer causes & control : CCC2017

Cigarette smoking and the association with serous ovarian cancer in African American women: African American Cancer Epidemiology Study (AACES).

Linda E Kelemen, Sarah Abbott, Bo Qin, Lauren Cole Peres, Patricia G Moorman, Kristin Wallace, Elisa V Bandera, Jill S Barnholtz-Sloan, Melissa Bondy, Kathleen Cartmell and 8 more

Abstract read
In one paragraph

Article in Cancer causes & control : CCC, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Association between Cigarette Smoking and Histotype-Specific Epithelial Ovarian Cancer: A Review of Epidemiologic Studies.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2019
    Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 10 institutions in 1 country.

Linda E KelemenDepartment of Public Health Sciences, Medical University of South Carolina, Bioengineering Building, MSC955, 68 President Street, Charleston, SC, 29425, USA. kelemen@musc.edu.
Sarah AbbottDepartment of Public Health Sciences, University of Virginia, Charlottesville, VA, USA.
Bo QinDepartment of Population Science, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Lauren Cole PeresDepartment of Public Health Sciences, University of Virginia, Charlottesville, VA, USA.
Patricia G MoormanDepartment of Community and Family Medicine, Duke Cancer Institute, Durham, NC, USA.
Kristin WallaceDepartment of Public Health Sciences, Medical University of South Carolina, Bioengineering Building, MSC955, 68 President Street, Charleston, SC, 29425, USA.
Elisa V BanderaDepartment of Population Science, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Jill S Barnholtz-SloanCase Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Melissa BondyDepartment of Medicine, Section of Epidemiology and Population Sciences, Baylor College of Medicine, Houston, TX, USA.
Kathleen CartmellCollege of Nursing, Medical University of South Carolina, Charleston, SC, USA.
Michele L CoteDepartment of Oncology and the Karmanos Cancer Institute, Population Studies and Disparities Research Program, Wayne State University School of Medicine, Detroit, MI, USA.
Ellen FunkhouserDivision of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Lisa E PaddockCancer Surveillance Research, Rutgers Cancer Institute of New Jersey and Rutgers School of Public Health, New Jersey State Cancer Registry, New Brunswick, NJ, USA.
Edward S PetersEpidemiology Program, Louisiana State University Health Sciences Center School of Public Health, New Orleans, LA, USA.
Ann G SchwartzDepartment of Oncology and the Karmanos Cancer Institute, Population Studies and Disparities Research Program, Wayne State University School of Medicine, Detroit, MI, USA.
Paul TerryDepartments of Public Health and Surgery, University of Tennessee-Knoxville, Knoxville, TN, USA.
Anthony J AlbergDepartment of Public Health Sciences, Medical University of South Carolina, Bioengineering Building, MSC955, 68 President Street, Charleston, SC, 29425, USA.
Joellen M SchildkrautDepartment of Public Health Sciences, University of Virginia, Charlottesville, VA, USA.
Medical University of South Carolina · USRutgers, The State University of New Jersey · USUniversity of Virginia · USThe Barbara Ann Karmanos Cancer Institute · USBaylor College of Medicine · USCase Western Reserve University · USDuke Medical Center · USKnoxville College · USLouisiana State University Health Sciences Center New Orleans · USUniversity of Alabama at Birmingham · US

Funding

TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Tracie Saunders · 1997 to 2026
$94.5M
Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI Julie Lynn Boerner · 1985 to 2026
$68.4M
Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Jian Ouyang · 2009 to 2026
$42.7M
Epidemiology of Ovarian Cancer in African-American WomenR01CA142081 · NCI · UNIVERSITY OF VIRGINIA · PI SCHILDKRAUT, JOELLEN M. · 2010 to 2015
$10.6M
TUMOR GROWTH AND METASTASISP30CA022435 · NCI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI FOGARTY, JOHN P · 1985 to 2007
$9.6M
NCI NIH HHS HHSN261201000028CNCI NIH HHS P30 CA022435NCI NIH HHS P30 CA022453NCI NIH HHS P30 CA072720NCI NIH HHS P30 CA138313NCI NIH HHS R01 CA142081
6 · The paper itself

Abstract

backgroundSmoking is a risk factor for mucinous ovarian cancer (OvCa) in Caucasians. Whether a similar association exists in African Americans (AA) is unknown.

methodsWe conducted a population-based case-control study of incident OvCa in AA women across 11 geographic locations in the US. A structured telephone interview asked about smoking, demographic, health, and lifestyle factors. Odds ratios and 95% confidence intervals (OR, 95% CI) were estimated from 613 cases and 752 controls using unconditional logistic regression in multivariable adjusted models.

resultsAssociations were greater in magnitude for serous OvCa than for all OvCa combined. Compared to never smokers, increased risk for serous OvCa was observed for lifetime ever smokers (1.46, 1.11-1.92), former smokers who quit within 0-2 years of diagnosis (5.48, 3.04-9.86), and for total pack-years smoked among lifetime ever smokers (0-5 pack-years: 1.79, 1.23-2.59; >5-20 pack-years: 1.52, 1.05-2.18; >20 pack-years: 0.98, 0.61-1.56); however, we observed no dose-response relationship with increasing duration or consumption and no significant associations among current smokers. Smoking was not significantly associated with mucinous OvCa. Associations for all OvCa combined were consistently elevated among former smokers. The proportion of ever smokers who quit within 0-2 years was greater among cases (23%) than controls (7%).

conclusionsCigarette smoking may be associated with serous OvCa among AA, which differs from associations reported among Caucasians. Exposure misclassification or reverse causality may partially explain the absence of increased risk among current smokers and lack of dose-response associations. Better characterization of smoking patterns is needed in this understudied population.

Indexed as

Black or African AmericanCase-Control StudiesFemaleHumansLogistic ModelsMiddle AgedOdds RatioOvarian NeoplasmsRisk FactorsSmokingCigarette smokingGynecologyOvarian neoplasmsPassive smokingRacial–ethnic differencesReverse causality

Identifiers

PMID28466107
PMCPMC5635599
OpenAlexW2611245105

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.